wayForward (Psyinnovations Inc.) a digital behavioral health company is now part of DarioHealth Corp. DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario's next-generation, AI-powered, digital therapeutic solutions support more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes, hypertension, musculoskeletal and behavioral health solutions on the market. The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users' health. Dario makes the right thing to do the easy thing to do. The world leading Dario Blood Glucose Monitoring System has US FDA clearance and approval from the European CE, Health Canada, and Australia’s TGA. Dario products are approved to sell in the United States, Canada, the United Kingdom, Germany, Italy, Australia, The Netherlands, and New Zealand. DarioHealth is rapidly moving into new geographic markets and chronic conditions. Company Mission: Empowering people to achieve healthier lives by engaging them with clinically proven digital tools that make the right thing to do, the easy thing to do.